| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.04 | 0.2 |
| mRNA | AZD4547 | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.041 | 0.2 |
| mRNA | Sunitinib | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | BRD-K13185470 | CTRPv2 | pan-cancer | AAC | 0.089 | 0.2 |
| mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | -0.096 | 0.2 |
| mRNA | prochlorperazine | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | AZD6244 | UHNBreast | pan-cancer | AAC | -0.37 | 0.2 |
| mRNA | BRD9647 | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |